Aprea Therapeutics, Inc.·4

Oct 16, 8:30 AM ET

Hamill John P. 4

4 · Aprea Therapeutics, Inc. · Filed Oct 16, 2024

Insider Transaction Report

Form 4
Period: 2024-10-11
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Transactions
  • Purchase

    Common Stock

    2024-10-11$2.46/sh+50$12319,368 total

Documents

1 file
  • 4
    tm2426059-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT